Pierre Bédossa
- Hepatology top 0.01%
- Hepatitis C virus research 105
- Liver Disease and Transplantation 56
- Liver Diseases and Immunity 45
- Hepatocellular Carcinoma Treatment and Prognosis 37
- Epidemiology top 0.01%
- Liver Disease Diagnosis and Treatment 264
- Hepatitis B Virus Studies 65
-
- Diet, Metabolism, and Disease 30
- Pathology and Forensic Medicine top 0.2%
- Alcohol Consumption and Health Effects 34
- Surgery top 0.2%
- Co-authors
- Thierry PoynardValérie ParadisP OpolonDelphine DargèreMichel VidaudPatrick MarcellinKarine ClémentDominique Valla
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Pierre Bédossa
500 papers receiving 37.6k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Hepatology 22.2k
- Epidemiology 28.0k
- Endocrinology, Diabetes and Metabolism 4.1k
- Pathology and Forensic Medicine 2.8k
- Surgery 5.6k
Countries citing papers authored by Pierre Bédossa
This map shows the geographic impact of Pierre Bédossa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Bédossa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Bédossa more than expected).
Fields of papers citing papers by Pierre Bédossa
This network shows the impact of papers produced by Pierre Bédossa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Bédossa. The network helps show where Pierre Bédossa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pierre Bédossa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 9 | |
| 5 | 2023 | 5 | |
| 6 | Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screeningbreakdown → | 2020 | 231 |
| 7 | The PanPPAR agonist lanifibranor induces both resolution of NASH and regression of fibrosis after 24 weeks of treatment in non-cirrhotic NASH: results of the NATIVE Phase 2b trial | 2020 | 18 |
| 8 | 2018 | 9 | |
| 9 | 2018 | 13 | |
| 10 | 2017 | 246 | |
| 11 | 2017 | 24 | |
| 12 | Staging fibrosis and excluding advanced fibrosis in patients with NAFLD: comparison of non-invasive markers in an interim analysis from a prospective multicentre study | 2016 | 0 |
| 13 | 2015 | 15 | |
| 14 | 2014 | 29 | |
| 15 | 2014 | 18 | |
| 16 | 2011 | 78 | |
| 17 | Serum alpha-foetoprotein level predicts treatment outcome in chronic hepatitis C. | 2007 | 40 |
| 18 | 2003 | 11 | |
| 19 | 2003 | 60 | |
| 20 | 1996 | 68 |
About Pierre Bédossa
Pierre Bédossa is a scholar working on Hepatology, Epidemiology, Pathology and Forensic Medicine, Surgery and Endocrinology, Diabetes and Metabolism, having authored 514 papers that have together received 38.5k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (264 papers), Hepatitis C virus research (105 papers), Hepatitis B Virus Studies (65 papers), Liver Disease and Transplantation (56 papers), Liver Diseases and Immunity (45 papers), Hepatocellular Carcinoma Treatment and Prognosis (37 papers), Alcohol Consumption and Health Effects (34 papers) and Diet, Metabolism, and Disease (30 papers). The work is most often cited by research in Hepatology (22.2k citations), Epidemiology (28.0k citations), Endocrinology, Diabetes and Metabolism (4.1k citations), Pathology and Forensic Medicine (2.8k citations) and Surgery (5.6k citations). Pierre Bédossa has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Thierry Poynard, Valérie Paradis, P Opolon, Delphine Dargère, Michel Vidaud, Patrick Marcellin, Karine Clément, Dominique Valla, Joan Tordjman and Jacques Belghiti. Their work appears in journals such as Journal of Hepatology, Hepatology, Gastroenterology, Liver International and Human Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.